Shares of Kairos Pharma Ltd. (KAPA), which gained nearly 6.29 % yesterday, are up another 20% in premarket hours today, trading at $1.92.
This clinical-stage biopharmaceutical company focused on developing cancer therapies will be presenting a talk on its investigational compound KROS 101 at the 13th AACR-JCA Joint Conference tomorrow.
KROS 101 is a small molecule agonist designed to target the GITR ligand and improve immune responses against tumors. It is under preclinical development.
For comments and feedback contact: editorial@rttnews.com
Economic News
What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.